[1] 史凤芹, 于世凤. 牙周炎牙槽骨吸收的基础研究-PGE2对破骨细胞性骨吸收的作用[J]. 现代口腔医学杂志, 1993, 7(1):4-6. [2] Intini G, Katsuragi Y, Kirkwood KL, et al. Alveolar bone loss: mechanisms, potential therapeutic targets, and interventions [J]. Adv Dent Res, 2014, 26(1):38-46. [3] Caetano-Lopes J, Canhäo H, Fonseca JE. Osteoblasts and bone formation [J]. Acta Reumatol Port, 2007, 32(2):103-110. [4] Ohata Y, Ozono K. Bone and Stem Cells. The mechanism of osteogenic differentiation from mesenchymal stem cell [J]. Clinical Calcium, 2014, 24(4):501-508. [5] Mbalaviele G, Jaiswal N, Meng A, et al. Human mesenchymal stem cells promote human osteoclast differentiation from CD34+ bone marrow hematopoietic progenitors [J]. Endocrinology, 1999, 140(8):3736-3743. [6] Lepperdinger G. Inflammation and mesenchymal stem cell aging [J]. Curr Opin Immunol, 2011, 23(4):518-524. [7] Usui M, Okamatsu Y, Sato T, et al. Thymus-expressed chemokine enhances Porphyromonas gingivalis LPS-induced osteoclast formation via NFATc1 activation[J]. Arch Oral Biol, 2016, 66:77-85. [8] Baud'huin M, Duplomb L, Ruiz Velasco C, et al. Key roles of the OPG-RANK-RANKL system in bone oncology [J]. Expert Rev Anticancer Ther, 2007, 7(2): 221-232. [9] Ross FP, Teitelbaum SL. alphavbeta3 and macrophage colony-stimulating factor: partners in osteoclast biology [J]. Immunol Rev, 2005, 208:88-105. [10] Douglass TG, Driggers L, Zhang JG, et al. Macrophage colony stimulating factor: not just for macrophages anymore! A gateway into complex biologies[J]. Int Immunopharmacol, 2008, 8(10):1354-1376. [11] Kimura K, Kitaura H, Fujii T, et al. An anti-c-Fms antibody inhibits osteoclastogenesis in a mouse periodontitis model [J]. Oral Dis, 2014, 20(3):319-324. [12] Lee SC, Liu W, Roth P, et al. Macrophage colony-stimulating factor in human fetal astrocytes and microglia. Differential regulation by cytokines and lipopolysaccharide, and modulation of class II MHC on microglia [J]. J Immunol, 1993, 150(2):594-604. [13] Eaves AC, Bruce WR. In vitro production of colony-stimulating activity. I. Exposure of mouse peritoneal cells to endotoxin [J]. Cell Tissue Kinet, 1974, 7(1):19-30. [14] Takaishi T, Matsui T, Tsukamoto T, et al. TGF-beta-induced macrophage colony-stimulating factor gene expression in various mesenchymal cell lines[J]. Am J Physiol, 1994, 267(1 Pt 1):25-31. [15] Teitelbaum SL. Bone resorption by osteoclasts [J]. Science, 2000, 289(5484):1504-1508. [16] Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation [J]. Cell, 1998, 93(2):165-176. [17] Anderson DM, Maraskovsky E, Billingsley WL, et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function[J]. Nature, 1997, 390(6656):175-179. [18] Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density [J]. Cell, 1997, 89(2):309-319. [19] Ibrahim T, Flamini E, Mercatali L, et al. Pathogenesis of osteoblastic bone metastases from prostate cancer[J]. Cancer, 2010, 116(6):1406-1418. [20] Boyce BF, Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling [J]. Arch Biochem Biophys, 2008, 473(2):139-146. [21] Silva I, Branco JC. Rank/Rankl/opg: literature review [J]. Acta Reumatol Port, 2011, 36(3):209-218. [22] 张晶, 向晓明, 李成章. RANKL/RANK/OPG调节系统在牙周炎发病机制中的作用[J]. 口腔医学研究, 2005, 21(4):472-474.
|